Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →21
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,297
Total Claims
$2.2M
Drug Cost
752
Beneficiaries
$2,948
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-78%
Opioid rate vs peers
0.8% vs 3.8% avg
+151%
Cost per patient vs peers
$2,948 vs $1,174 avg
+157%
Brand preference vs peers
22.8% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.8%
Opioid Rate
87
Opioid Claims
$2,045
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,299 claims · $1.8M
Generic: 7,797 claims · $375K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Diclofenac Sodium | 162 | $526K |
| Diclofenac Sodium | 150 | $153K |
| Linaclotide | 149 | $93K |
| Apixaban | 98 | $80K |
| Cyclosporine | 84 | $71K |
| Lipase/Protease/Amylase | 53 | $68K |
| Icosapent Ethyl | 150 | $55K |
| Sitagliptin Phosphate | 45 | $53K |
| Lipase/Protease/Amylase | 19 | $50K |
| Empagliflozin | 49 | $43K |
| Semaglutide | 28 | $41K |
| Lactulose | 35 | $37K |
| Efinaconazole | 26 | $35K |
| Insulin Lispro | 25 | $34K |
| Linagliptin | 34 | $32K |
Prescribing Profile
Patient Profile
75
Avg Age
67%
Female
1.82
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About